ACETYL HEXAPEPTIDE-8 (ARGIRELINE®), a hexapeptide Ac-EEMQRR-NH2, is an anti-wrinkling agent. It significantly inhibits neurotransmitter release with a potency similar to that of botulinum toxin. ACETYL HEXAPEPTIDE-8 (ARGIRELINE®) is a mimic of the N-terminal end of SNAP-25 which competes with SNAP-25 for a position in the SNARE complex, thereby modulating its formation. If the SNARE complex is slightly destabilized, the vesicle can not release neurotransmitters efficiently and therefore muscle contraction is attenuated, preventing the formation of lines and wrinkles.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The study of cellular cytotoxicity of argireline - an anti-aging peptide. | 2014 |
|
| The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. | 2013-04 |
|
| Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. | 2013-03 |
|
| Preparation and stability of cosmetic formulations with an anti-aging peptide. | 2006-11-21 |
|
| A synthetic hexapeptide (Argireline) with antiwrinkle activity. | 2002-10 |
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 21:25:13 GMT 2025
by
admin
on
Wed Apr 02 21:25:13 GMT 2025
|
| Protein Type | PEPTIDE |
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
L4EL31FWIL
|
| Record Status |
FAILED
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
616204-22-9
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY | |||
|
ACETYL HEXAPEPTIDE-3
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY | |||
|
11228338
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY | |||
|
DB11709
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY | |||
|
L4EL31FWIL
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY | |||
|
1314329
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY | RxNorm | ||
|
L4EL31FWIL
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY | |||
|
DTXSID201021291
Created by
admin on Wed Apr 02 21:25:13 GMT 2025 , Edited by admin on Wed Apr 02 21:25:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_6] | ARGININAMIDE, L- | 29626ZE0WY | |||
| AMINO_ACID_SUBSTITUTION | [1_1] | ACETYL GLUTAMIC ACID | MA61H539YZ |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|